Universitätsklinikum Schleswig-Holstein (UKSH)

Hospital


Location: Lübeck / Kiel, Germany (DE) DE

ISNI: 0000000406462097

ROR: https://ror.org/01tvm6f46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life (2022) Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, et al. Journal article Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer (2022) Mohr T, Zwick A, Hans MC, Bley IA, Braun FL, Khalmurzaev O, Matveev VB, et al. Journal article Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) Rogers S, Baumert BG, Blanck O, Boehmer D, Bostroem J, Engenhart-Cabillic R, Ermis E, et al. Journal article Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution Isolation and characterization of extracellular vesicles (EVs) from ovarian cancer ascites - a feasibility study (2022) Reinhardt N, Lettau M, Hugendieck G, Neumann S, Rogmans C, Weimer JP, Floerkemeier , et al. Conference contribution Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article Digital and innovative teaching in dermatology Practically oriented teaching online (2022) Wittbecker LM, Pham C, Wohlgemuth LK, Hoang MA, Bandholz TC, Schuh S, Gihl J, et al. Journal article Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial (2022) Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, et al. Journal article